Cannabinoids modulate ultrasound-induced aversive responses in rats

Psychopharmacology

Volumn 172, Issue 1, 2004, Pages 41-51

  Finn, David P ^a   Jhaveri, Maulik D ^a   Beckett, Simon R G ^a   Kendall, David A ^a   Marsden, Charles A ^a   Chapman, Victoria ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aversion; Cannabinoid receptor; HPA axis; Panic; Periaqueductal grey; Ultrasound

Indexed keywords

CANNABINOID 1 RECEPTOR; CORTICOSTERONE; DEXANABINOL; RIMONABANT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; BIOLOGICAL MONITORING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG POTENTIATION; HYPERTHERMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOCOMOTION; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; ULTRASOUND;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; MALE; PANIC; PERIAQUEDUCTAL GRAY; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; ULTRASONICS;

EID: 1542374192     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1629-1     Document Type: Article

References (54)

1. Annis HM, Smart RG (1973) Adverse reactions and recurrences from marihuana use. Br J Addict Alcohol Other Drugs 68:315-319
2. Bandler R, Keay KA (1996) Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. Prog Brain Res 107:285-300
3. Bandler R, Carrive P, Zhang SP (1991) Integration of somatic and autonomic reactions within the midbrain periaqueductal grey: viscerotopic, somatotopic and functional organization. Prog Brain Res 87:269-305
4. 1 receptor agonists administered into the periaqueductal gray. Psychopharmacology 108:110-114
5. Beckett SR, Aspley S, Graham M, Marsden CA (1996) Pharmacological manipulation of ultrasound induced defence behaviour in the rat. Psychopharmacology 127:384-390
6. Beckett SR, Duxon MS, Aspley S, Marsden CA (1997) Central c-fos expression following 20 kHz/ultrasound induced defence behaviour in the rat. Brain Res Bull 42:421-426
7. Berrendero F, Maldonado R (2002) Involvement of the opioid system in the anxiolytic-like effects induced by delta(9)-tetrahydrocannabinol. Psychopharmacology 163:111-117
8. Blanchard RJ, Blanchard DC (1989) Antipredator defensive behaviors in a visible burrow system. J Comp Psychol 103:70-82
9. Blanchard RJ, Flannelly KJ, Blanchard DC (1986) Defensive behaviors of laboratory and wild Rattus norvegicus. J Comp Psychol 100:101-107
10. Blanchard RJ, Blanchard DC, Agullana R, Weiss SM (1991) Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiol Behav 50:967-972
11. Blanchard RJ, Yang M, Li CI, Gervacio A, Blanchard DC (2001) Cue and context conditioning of defensive behaviors to cat odor stimuli. Neurosci Biobehav Rev 25:587-595
12. Brudzynski SM, Chiu EMC (1995) Behavioural responses of laboratory rats to playback of 22 kHz ultrasonic calls. Physiol Behav 57:1039-1044
13. Cheer JF, Kendall DA, Marsden CA (2000a) Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology 151:25-30
14. Cheer JF, Marsden CA, Kendall DA, Mason R (2000b) Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. Neuroscience 99:661-667
15. Commissaris RL, Palmer A, Neophytou S, Graham M, Beckett S, Marsden CA (2000) Acoustically elicited behaviours in Lister hooded and Wistar rats. Physiol Behav 68:521-531
16. Deakin JFW, Graeff FG (1991) 5-HT and mechanisms of defence. J. Psychopharmacol 5:305-315
17. Finn DP, Chapman V, Jhaveri MD, Samanta S, Manders T, Bowden J, Matthews L, Marsden CA, Beckett SRG (2003a) The role of the central nucleus of the amygdala in nociception and aversion. Neuroreport 14:981-984
18. Finn DP, Jhaveri MD, Beckett SRG, Roe CH, Kendall DA, Marsden CA, Chapman V (2003b) Effects of direct PAG administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45:594-604
19. French ED (1997) Delta(9)-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159-162
20. Graeff FG (1988) Animal models of aversion. In: Simon PS, Wildlocher D (eds) Animal models of psychiatric disorders. Karger, Basel, pp 115-141
21. Herkenham M, Lynn AB, Johnson MR, Melvin MS, de Costa BR, Rice KC (1990) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:463-483
22. Hilton SM, Redfern WS (1986) A search for brain stem cell groups integrating the defence reaction in the rat. J Physiol 378:213-228
23. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20
24. Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J, Maldonado R (1998) Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Br J Pharmacol 125:1567-1577
25. Lovick TA (2000) Panic disorder - a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter? Neuroscientist 6:48-59
26. Maione S, Palazzo E, de Novellis V, Stella L, Leyva J, Rossi F (1998) Metabotropic glutamate receptors modulate serotonin release in the rat periaqueductal gray matter. Naunyn-Schmiedeberg's Arch Pharmacol 358:411-417
27. Maldonado R, Rodríguez de Fonseca F (2002) Cannabinoid addiction: Behavioral models and neural correlates. J Neurosci 22:3326-3331
28. Manzanares J, Corchero J, Fuentes JA (1999) Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res 839:173-179
29. Martin WJ, Tsou K, Walker JM (1998) Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neurosci Lett 242:33-36
30. Martin-Calderon JL, Munoz RM, Villanua MA, del Arco I, Moreno JL, Rodríguez de Fonseca F, Navarro M (1998) Characterization of the acute endocrine actions of (-)-11-hydroxy-delta(8)-tetrahydrocannabinol- dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats. Eur J Pharmacol 344:77-86
31. McGregor IS, Dastur FN, McLellan RA, Brown RE (1996a) Cannabinoid modulation of rat pup ultrasonic vocalizations. Eur J Pharmacol 313:43-49
32. McGregor IS, Issakidis CN, Prior G (1996b) Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol Biochem Behav 53:657-664
33. Navarro M, Fernandezruiz JJ, Demiguel R, Hernandez ML, Cebeira M, Ramos JA (1993) An acute dose of delta(9)-tetrahydrocannabinol affects behavioral and neurochemical indexes of mesolimbic dopaminergic activity. Behav Brain Res 57:37-46
34. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F (1997a) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8:491-496
35. Navarro M, Hernandez E, Munoz RM, delArco I, Villanua MA, Carrera MRA, deFonseca FR (1997b) Acute administration of the CB1 cannabinoid receptor antagonist SR141716A induces anxiety-like responses in the rat. Neuroreport 8:491-496
36. Neophytou SI, Graham M, Williams J, Aspley S, Marsden CA, Beckett SR (2000) Strain differences to the effects of aversive frequency ultrasound on behaviour and brain topography of c-fos expression in the rat. Brain Res 854:158-164
37. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002-1009
38. Parker LA, Gillies T (1995) THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav Neurosci 109:71-78
39. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, New York
40. Rodriguez de Fonseca F, Villanua MA, Munoz RM, Sanmartinclark O, Navarro M (1995) Differential effects of chronic treatment with either dopamine d-1 or d-2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats. Neuroendocrinology 61:714-721
41. Rodríguez de Fonseca F, Rubio P, Menzaghi F, MerloPich E, Rivier J, Koob GF, Navarro M (1996) Corticotropin-releasing factor (CRF) antagonist [D-Phe(12),Nle(21,38),C(alpha)-Me-Leu(37)]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther 276:56-64
42. Rodríguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276:2050-2054
43. Romero EM, Fernandez B, Sagredo O, Gomez N, Uriguen L, Guaza C, De Miguel R, Ramos JA, Viveros MP (2002) Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats. Dev Brain Res 136:85-92
44. Sales GD (1972) Ultrasound and aggressive behaviour in rats and other small mammals. Anim Behav 20:88-100
45. Sanudo-Pena MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125-128
46. Schutz MT, de Aguiar JC, Graeff FG (1985) Anti-aversive role of serotonin in the dorsal periaqueductal grey matter. Psychopharmacology 85:340-345
47. Thomas H (1996) A community survey of adverse effects of cannabis use. Drug Alcohol Depend 42:201-207
48. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83:393-411
49. van der Poel AM, Noach EJ, Miczek KA (1989) Temporal patterning of ultrasonic distress calls in the adult rat: effects of morphine and benzodiazepines. Psychopharmacology 97:147-148
50. Vaughan CW, Connor M, Bagley EE, Christie MJ (2000) Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol 57:288-295
51. Weidenfeld J, Feldman S, Mechoulam R (1994) Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pitutary-adrenal axis in the rat. Neuroendocrinology 59:110-112
52. Welch SP, Huffman JW, Lowe J (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J Pharmacol Exp Ther 287:1301-1308
53. Windle RJ, Wood SA, Kershaw YM, Lightman SL, Ingram CD, Harbuz MS (2001) Increased corticosterone pulse frequency during adjuvant-induced arthritis and its relationship to alterations in stress responsiveness. J Neuroendocrinol 13:905-911
54. Zhang YQ, Gao X, Zhang LM, Wu GC (2000) The release of serotonin in rat spinal dorsal horn and periaqueductal gray following carrageenan inflammation. Neuroreport 11:3539-3543